Evidence map›Paper›PMID 22900100›Full record

ArticlePloS one2012

Negative selection assay based on stimulation of T cell receptor transgenic thymocytes with peptide-MHC tetramers.

Vasily Rybakin, Nicholas R J Gascoigne

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vasily RybakinDepartment of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California, United States of America. vrybakin@scripps.edu
Nicholas R J Gascoigne
Scripps Research Institute · US

Funding

Intermolecular Interactions in the Immunological SynapseR01GM065230 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SAUER, KARSTEN · 2002 to 2014
$4.6M
Soluble T Cel Receptor Studies on MHC RestrictionR01AI074074 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI GASCOIGNE, NICHOLAS R · 2007 to 2011
$2.2M
A novel protein regulating thymocyte developmentR01AI073870 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI GASCOIGNE, NICHOLAS R · 2009 to 2010
$950k
Themis Regulation of Thymocyte SelectionR56AI073870 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI GASCOIGNE, NICHOLAS R · 2011 to 2011
$474k
NIAID NIH HHS AI073870NIAID NIH HHS AI074074NIAID NIH HHS R01 AI073870NIAID NIH HHS R01 AI074074NIAID NIH HHS R56 AI073870NIGMS NIH HHS GM065230NIGMS NIH HHS R01 GM065230
6 · The paper itself

Abstract

Thymocyte negative selection is a requirement for the development of self tolerance. Although it is possible to assay the induction of cell death in thymocytes in vitro using antibody cross-linking, this stimulus is much stronger than the normal range of T cell receptor ligands that could be encountered during normal development. Signaling in thymocytes is finely balanced between positive and negative selection stimuli, where a negative selecting ligand can be only marginally higher affinity than a positive selecting ligand. We have therefore developed an assay for the induction of negative selection that can distinguish such cases, and that is amenable to high-throughput analysis. The assay is based on the induction of activated caspase 3 in thymocytes expressing a defined T cell receptor, after stimulation with MHC-peptide tetramers in vitro for 24 hours or less.

Indexed as

AnimalsApoptosisCaspase 3Cell DifferentiationClonal DeletionHistocompatibility AntigensHumansLymphocyte ActivationMiceMice, TransgenicPeptidesReceptors, Antigen, T-CellThymocytesCaspase 3Histocompatibility AntigensPeptidesReceptors, Antigen, T-Cell

Identifiers

PMID22900100
PMCPMC3416795
OpenAlexW2005145278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.